Series B · Biotech
Spot Biosystems: Series B
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
Funding history
Series B · This round$40M
Loading rounds…
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines